Computed tomography screening for lung cancer - 01/09/11
Doi : 10.1016/S0272-5231(03)00059-5
Claudia I Henschke, PhD, MD ⁎, a 
, David F Yankelevitz, MD a, Daniel Libby, MD b, Dorothy McCauley, MD a, Mark Pasmantier, MD c, James P Smith, MD b
, David F Yankelevitz, MD a, Daniel Libby, MD b, Dorothy McCauley, MD a, Mark Pasmantier, MD c, James P Smith, MD b a Department of Radiology Weill Medical College of Cornell University, New York, New York USA
b Department of Medicine, Division of Pulmonary and Critical Care Medicine Weill Medical College of Cornell University, New York, New York USA
c Department of Medicine, Division of Hematology and Oncology, Weill Medical College of Cornell University, New York, New York USA
Address reprint requests to: Claudia I. Henschke, PhD, MD Department of Radiology Weill Medical College of Cornell University 525 East 68 Street New York, NY 10021Résumé |
The development of CT technology reopened the lung cancer screening debate. Computed tomography screening for lung cancer certainly meets all the criteria required for an appropriate screening test. First and perhaps most importantly, the disease for which the screening is being performed should have a significant prevalence in the population being studied and be a significant health risk for those afflicted with it. Lung cancer is the leading cause of cancer death in both men and women, and one of the most lethal of all cancers.
Le texte complet de cet article est disponible en PDF.Plan
© 2001
W.B. Saunders Company. Tous droits réservés.
Vol 23 - N° 1
P. 49-57 - mars 2002 Retour au numéro
Article précédent
- Lung cancer evolution to preinvasive management
- James L Mulshine, Frank Cuttitta, Melvyn S Tockman, Luigi M De Luca
- Diagnosis of roentgenographically occult lung cancer by sputum cytology
- Thomas L Petty, Melvyn S Tockman, Branko Palcic
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?